The Effect of Streptomyces-Derived Bioactive Compounds on IL-6 Levels Exploring Antimicrobial and Anti-inflammatory Properties in Bacterial Infections
Abstract
Background: Streptomyces, a genus of Actinomycetes, are known for their ability to produce bioactive compounds, including antibiotics, with significant applications in medicine and agriculture.
Objective: This study’s aim is to investigate the effects of extracellular extracts from Streptomyces spp. on the inflammatory response, specifically interleukin-6 (IL-6), in various bacterial infection models.
Methods: Through 16S rRNA gene sequencing, the T2 strain was identified and shown to share a high similarity with S. actinomycinicus. Phylogenetic analysis confirmed its close evolutionary relationship with other species in the Streptomyces genus.
Results: The study found that IL-6 levels were significantly elevated in infections caused by both sensitive and resistant bacterial strains, with resistant strains showing the highest inflammatory response. Post-infection treatment with Streptomyces extracts effectively reduced IL-6 levels in sensitive bacterial infections, demonstrating the extract’s potential antimicrobial properties. However, the treatment had limited effectiveness in resistant infections, as indicated by persistent high IL-6 levels. The extract alone did not significantly alter IL-6 levels, suggesting anti-inflammatory properties without triggering an immune response.
Conclusion: Streptomyces extracts may reduce bacterial load and inflammation in infections, but limited effectiveness on resistant strains necessitates further research for more potent antibiotic-resistant treatments.
How to cite this article:
Mohammed B Q, Risan M H, Issa Y W. The Effect
of Streptomyces-Derived Bioactive Compounds
on IL-6 Levels Exploring Antimicrobial and Anti
inflammatory Properties in Bacterial Infections.
J Commun Dis. 2025;57(2):136-141.
DOI: https://doi.org/10.24321/0019.5138.202549
References
Saif AS, Salih SM, Issa YW. Immunological Profiling of Toll-Like Receptor 3, Interferon-Alpha, and Antimicrobial Peptide LL-37 in Response to COVID-19 Infection and Vaccination in Iraqi Patients. J. Commun. Dis. 2024;56(4):4.[Google Scholar]
Giufrè M, Cardines R, Brigante G, Orecchioni F, Cerquetti M. Emergence of invasive Haemophilus influenzae type a disease in Italy. Clinical Infectious Diseases. 2017 Jun 1;64(11):1626-8. [Google Scholar]
Copyright (c) 2025 Journal of Communicable Diseases (E-ISSN: 2581-351X & P-ISSN: 0019-5138)

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.